» Articles » PMID: 39207041

Myeloid Cells and Sensory Nerves Mediate Peritendinous Adhesion Formation Via Prostaglandin E2

Overview
Journal Adv Sci (Weinh)
Date 2024 Aug 29
PMID 39207041
Authors
Affiliations
Soon will be listed here.
Abstract

Peritendinous adhesion that forms after tendon injury substantially limits daily life. The pathology of adhesion involves inflammation and the associated proliferation. However, the current studies on this condition are lacking, previous studies reveal that cyclooxygenase-2 (COX2) gene inhibitors have anti-adhesion effects through reducing prostaglandin E2 (PGE2) and the proliferation of fibroblasts, are contrary to the failure in anti-adhesion through deletion of EP4 (prostaglandin E receptor 4) gene in fibroblasts in mice of another study. In this study, single-cell RNA sequencing analysis of human and mouse specimens are combined with eight types of conditional knockout mice and further reveal that deletion of COX2 in myeloid cells and deletion of EP4 gene in sensory nerves decrease adhesion and impair the biomechanical properties of repaired tendons. Furthermore, the COX2 inhibitor parecoxib reduces PGE2 but impairs the biomechanical properties of repaired tendons. Interestingly, PGE2 local treatment improves the biomechanical properties of the repaired tendons. These findings clarify the complex role of PGE2 in peritendinous adhesion formation (PAF) and tendon repair.

Citing Articles

Myeloid Cells and Sensory Nerves Mediate Peritendinous Adhesion Formation via Prostaglandin E2.

Zhang X, Xiao Y, Tao Z, Zhang Y, Cheng X, Liu X Adv Sci (Weinh). 2024; 11(40):e2405367.

PMID: 39207041 PMC: 11516151. DOI: 10.1002/advs.202405367.

References
1.
Sauerschnig M, Stolberg-Stolberg J, Schmidt C, Wienerroither V, Plecko M, Schlichting K . Effect of COX-2 inhibition on tendon-to-bone healing and PGE2 concentration after anterior cruciate ligament reconstruction. Eur J Med Res. 2018; 23(1):1. PMC: 5756348. DOI: 10.1186/s40001-017-0297-2. View

2.
Cheng S, Li Z, Gao R, Xing B, Gao Y, Yang Y . A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells. Cell. 2021; 184(3):792-809.e23. DOI: 10.1016/j.cell.2021.01.010. View

3.
Skirven T, DeTullio L . Therapy after Flexor Tendon Repair. Hand Clin. 2023; 39(2):181-192. DOI: 10.1016/j.hcl.2022.08.019. View

4.
Yang R, Xu T, Zhang L, Ge M, Yan L, Li J . A single-cell atlas depicting the cellular and molecular features in human anterior cruciate ligamental degeneration: A single cell combined spatial transcriptomics study. Elife. 2023; 12. PMC: 10688969. DOI: 10.7554/eLife.85700. View

5.
Cartron G, Ohresser M, Salles G, Solal-Celigny P, Colombat P, Watier H . Neutrophil role in in vivo anti-lymphoma activity of rituximab: FCGR3B-NA1/NA2 polymorphism does not influence response and survival after rituximab treatment. Ann Oncol. 2008; 19(8):1485-1487. DOI: 10.1093/annonc/mdn163. View